Volume 34 Number 8 February 26 - March 5, 2015
Cancer
A modified Lynch syndrome screening algorithm in colon cancer: BRAF immunohistochemistry is efficacious and cost beneficial.
Roth Rachel M et al. Am. J. Clin. Pathol. 2015 3 0. (3) 336-43
Roth Rachel M et al. Am. J. Clin. Pathol. 2015 3 0. (3) 336-43
Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
Meisel Susanne F et al. Breast 2015 2 20.
Meisel Susanne F et al. Breast 2015 2 20.
End of cancer-genome project prompts rethink.
Ledford Heidi et al. Nature 2015 1 8. (7533) 128-9
Ledford Heidi et al. Nature 2015 1 8. (7533) 128-9
Family history of prostate cancer in men being followed by active surveillance does not increase risk of being diagnosed with high-grade disease.
Selkirk Christina G et al. Urology 2015 2 20.
Selkirk Christina G et al. Urology 2015 2 20.
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.
Den RB, et al. J Clin Oncol. 2015 Feb 9. pii: JCO.2014.59.0026.
Den RB, et al. J Clin Oncol. 2015 Feb 9. pii: JCO.2014.59.0026.
Practical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families.
Patel S G et al. Dig. Dis. Sci. 2015 2 20.
Patel S G et al. Dig. Dis. Sci. 2015 2 20.
Precision medicine to improve the risk and benefit of cancer care
Howard L. McLeod JAMA 2015 Feb 24
Howard L. McLeod JAMA 2015 Feb 24
Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.
Wong-Brown MW, et al. Breast Cancer Res Treat. 2015 Feb 15.
Wong-Brown MW, et al. Breast Cancer Res Treat. 2015 Feb 15.
Breast cancer gene breakthrough, Healthcanal, Feb 24
Utility of next generation sequencing technologies for the efficient genetic resolution of haematological disorders.
Zhang Jianguo et al. Clin. Genet. 2015 2 20.
Zhang Jianguo et al. Clin. Genet. 2015 2 20.
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.
Wevers M R et al. Fam. Cancer 2015 2 21.
Wevers M R et al. Fam. Cancer 2015 2 21.
No hay comentarios:
Publicar un comentario